Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 34.25 | 2.24% | 0.75 |
CRBP closed up 2.24 percent on Friday, April 26, 2024, on 32 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 2.24% | |
| Bollinger Band Squeeze | Range Contraction | 2.24% | |
| Stochastic Reached Oversold | Weakness | 2.24% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 2.24% |
| Alert | Time |
|---|---|
| Up 3% | about 14 hours ago |
| Possible NR7 | about 15 hours ago |
| Possible Inside Day | about 15 hours ago |
| Rose Above Lower Bollinger Band | about 15 hours ago |
| Up 2% | about 15 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Treatment Of Cystic Fibrosis Ajulemic Acid Channelopathies Scleroderma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Treatment Of Cystic Fibrosis Ajulemic Acid Channelopathies Scleroderma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 49.8699 |
| 52 Week Low | 3.0334 |
| Average Volume | 302,859 |
| 200-Day Moving Average | 14.94 |
| 50-Day Moving Average | 36.25 |
| 20-Day Moving Average | 38.25 |
| 10-Day Moving Average | 37.55 |
| Average True Range | 3.55 |
| RSI (14) | 43.18 |
| ADX | 21.41 |
| +DI | 19.42 |
| -DI | 24.53 |
| Chandelier Exit (Long, 3 ATRs) | 34.34 |
| Chandelier Exit (Short, 3 ATRs) | 42.69 |
| Upper Bollinger Bands | 42.68 |
| Lower Bollinger Band | 33.82 |
| Percent B (%b) | 0.05 |
| BandWidth | 23.16 |
| MACD Line | -0.27 |
| MACD Signal Line | 0.62 |
| MACD Histogram | -0.8941 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 37.78 | ||||
| Resistance 3 (R3) | 37.52 | 36.07 | 37.19 | ||
| Resistance 2 (R2) | 36.07 | 35.17 | 36.20 | 37.00 | |
| Resistance 1 (R1) | 35.16 | 34.61 | 35.62 | 35.43 | 36.80 |
| Pivot Point | 33.72 | 33.72 | 33.94 | 33.85 | 33.72 |
| Support 1 (S1) | 32.81 | 32.82 | 33.26 | 33.07 | 31.70 |
| Support 2 (S2) | 31.36 | 32.26 | 31.49 | 31.50 | |
| Support 3 (S3) | 30.45 | 31.36 | 31.31 | ||
| Support 4 (S4) | 30.72 |
